反応式
[CH:1]1([CH2:6][OH:7])[CH2:5][CH2:4][CH2:3][CH2:2]1.F[C:9]1[CH:10]=[C:11]([CH3:18])[CH:12]=[CH:13][C:14]=1[N+:15]([O-:17])=[O:16].[CH:19]1([CH2:24][O:25][C:26]2[CH:32]=[C:31]([CH3:33])[CH:30]=[CH:29][C:27]=2[NH2:28])[CH2:23][CH2:22][CH2:21][CH2:20]1.[NH2:34][C:35]1[S:36][CH:37]=[CH:38][N:39]=1>>[CH:1]1([CH2:6][O:7][C:9]2[CH:10]=[C:11]([CH3:18])[CH:12]=[CH:13][C:14]=2[N+:15]([O-:17])=[O:16])[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH:19]1([CH2:24][O:25][C:26]2[CH:32]=[C:31]([CH3:33])[CH:30]=[CH:29][C:27]=2[NH:28][C:6]([NH:34][C:35]2[S:36][CH:37]=[CH:38][N:39]=2)=[O:7])[CH2:20][CH2:21][CH2:22][CH2:23]1参加物
6
実験手順
3-Cyclopentylmethoxy-4-nitrotoluene (0.82 g, 70%) was prepared from cyclopentylmethanol and 3-fluoro-4-nitrotoluene (0.77 g, 5.0 mmol) following the general procedure G. This was reduced to 2-cyclopentylmethoxy-4-methyl-aniline (0.58 g, 81%) following general procedure C. 1-(2-Cyclopentylmethoxy-4-methyl-phenyl)-3-thiazol-2-yl-urea (225 mg, 68%) was prepared from 2-cyclopentylmethoxy-4-methyl-aniline (205 mg, 1.0 mmol) and 2-aminothiazole (100 mg, 1.0 mmol) following the general procedure D.
出典と根拠
- ORDレコード
- ord-b502c7275be947ee877f96211fca518e
- 出典データセット
- uspto-grants-2009_06
- 特許番号
- US07541373B2
関連ノート
読み込み中…